Pancreatic Cancer Action Network Calls for Urgently Needed Research and Funding for Effective Early Detection Strategy and ...

A new mouse study by researchers at the University of California (UC), San Diego, School of Medicine reveals that an enzyme ...

Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and deadly forms of cancer. This means it grows and ...

Today the American Cancer Society called out the need for more progress on pancreatic cancer, citing it as the third-leading ...

Background and Aim: Intraductal papillary mucinous tumor (IPMT) of the pancreas can be divided into three clinically distinct subtypes: main duct type, branch duct type and mixed type. Although it ...

Recent advances in pancreatic cancer detection are offering hope, with new techniques and technologies aiming to identify the ...

A phase 2a trial of IMM-1-104 plus chemotherapy demonstrated efficacy and tolerability in first- and second-line pancreatic ...

Silexion Therapeutics' SIL-204 exhibits synergy with key pancreatic cancer drugs in preclinical studies. Phase 2/3 trials ...

Long before mRNA vaccines captured global attention during the COVID-19 pandemic, researchers were already exploring their ...

EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that the first ...

On second thought, the FDA figures it no longer needs to discuss Exelixis’ application for Cabometyx in neuroendocrine tumors ...